Cargando…
Daratumumab, an original approach for treating multi-refractory autoimmune cytopenia
Autores principales: | Crickx, Etienne, Audia, Sylvain, Robbins, Ailsa, Boutboul, David, Comont, Thibault, Cheminant, Morgane, Oksenhendler, Eric, Godeau, Bertrand, Michel, Marc, Mahevas, Matthieu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634173/ https://www.ncbi.nlm.nih.gov/pubmed/34348453 http://dx.doi.org/10.3324/haematol.2021.279232 |
Ejemplares similares
-
Older Adults and Immune Thrombocytopenia: Considerations for the Clinician
por: Crickx, Etienne, et al.
Publicado: (2023) -
P1613: REAL-WORLD USE OF FOSTAMATINIB IN FRANCE. INTERIM RESULTS OF A NATIONAL REGISTRY.
por: Moulis, Guillaume, et al.
Publicado: (2023) -
Refractory Autoimmune Cytopenias Treated With Venetoclax
por: Gordon, Max J., et al.
Publicado: (2019) -
Vaccination anti-SARS-CoV2 au cours de la thrombopénie immunologique de l’adulte: une étude observationnelle sur 195 patients
por: Crickx, E., et al.
Publicado: (2021) -
De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring
por: Moulis, Guillaume, et al.
Publicado: (2022)